Humoral and Cellular Immunity to Primary H1N1 Infection in Patients with Hematologic Malignancies following Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 5, 2011, Pages 632-639

  Garland, Paula ^a   de Lavallade, Hugues ^a   Sekine, Takuya ^a   Hoschler, Katja ^b   Sriskandan, Shiranee ^c   Patel, Parind ^c   Brett, Stephen ^c   Stringaris, Kate ^a   Loucaides, Eva ^a   Howe, Katherine ^a   Marin, David ^a   Kanfer, Ed ^a   Cooper, Nichola ^a   Macdonald, Donald ^a   Rahemtulla, Amin ^a   Atkins, Mark ^c   Danga, Akila ^c   Milojkovic, Dragana ^a   Gabriel, Ian ^a   Khoder, Ahmad ^a   Alsuliman, Abdullah ^a   Apperley, Jane ^a   Rezvani, Katayoun ^a   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Hematological malignancy; Immune response; Influenza; Swine flu

Indexed keywords

OSELTAMIVIR; ZANAMIVIR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC LYMPHOBLASTIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; FEMALE; FLOW CYTOMETRY; HEMAGGLUTINATION INHIBITION TEST; HOSPITALIZATION; HUMAN; HUMORAL IMMUNITY; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; LYMPHATIC LEUKEMIA; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; REAL TIME POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; T LYMPHOCYTE;

ADULT; AGED; ANTIBODIES; CASE-CONTROL STUDIES; CD40 LIGAND; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERFERON-GAMMA; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 79954618621     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.08.002     Document Type: Article

References (29)

1. Nichols W.G., Corey L., Gooley T., et al. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 2001, 98:573-578.
2. Garcia-Suarez J., Martin Y., Callejas M., et al. Favourable outcome of pneumonia due to novel influenza A/H1N1 2009 virus in a splenectomised adult patient undergoing therapy for non-Hodgkin lymphoma. Br J Haematol Epub 2009 Nov 16, 148(5):808-810.
3. Redelman-Sidi G., Sepkowitz K.A., Huang C.K., et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect Epub 2010 Feb 4, 60(4):257-263.
4. Rozovski U., Herishanu Y., Gipstein L., et al. Fatal H1N1 influenza infection in an allo-SCT recipient. Bone Marrow Transplant 2010, Letter, January 25.
5. Seiter K., Nadelman R.B., Liu D., et al. Novel influenza A (H1N1) in patients with hematologic malignancies. J Clin Oncol 2010, 28:e27-e29.
6. World Health Organization-CDC protocol of real time RTPCR for influenza A (H1N1). 2009, April 28; available online at:. http://www.who.int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf.
7. Ellis J.S., Zambon M.C. Molecular analysis of an outbreak of influenza in the United Kingdom. Eur J Epidemiol 1997, 13:369-372.
8. Nicholson K.G., Colegate A.E., Podda A., et al. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 2001, 357:1937-1943.
9. Clark T.W., Pareek M., Hoschler K., et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009, 361:2424-2435.
10. Miller E., Hoschler K., Hardelid P., et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010, Mar 27, 375(9720):1100-1108.
11. Chattopadhyay P.K., Yu J., Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med 2005, 11:1113-1117.
12. Rezvani K., Yong A.S., Tawab A., et al. Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia. Blood 2009, 113:2245-2255.
13. Hui D.S., Lee N., Chan P.K. Clinical management of pandemic (H1N1) infection. Chest 2009, Apr, 137(4):916-925.
14. Gaur A.H., Bagga B., Barman S., et al. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med 2010, 362:88-89.
15. Kidd I.M., Down J., Nastouli E., et al. H1N1 pneumonitis treated with intravenous zanamivir. Lancet 2009, 374:1036. (Case Report).
16. Chowell G., Bertozzi S.M., Colchero M.A., et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009, 361:674-679.
17. Donaldson L.J., Rutter P.D., Ellis B.M., et al. Comparisons with recent flu mortality. BMJ 2010, 340:c612. (Letter).
18. Perez-Padilla R., Rosa-Zamboni D., Ponce de L.S., et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361:680-689.
19. Cao B., Li X.W., Mao Y., et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009, 361:2507-2517.
20. Jain S., Kamimoto L., Bramley A.M., et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361:1935-1944.
21. Plennevaux E., Sheldon E., Blatter M., et al. Immune response after a single vaccination against 2009 influenza A H1N1 in the USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010, 375:41-48.
22. Greenberg M.E., Lai M.H., Hartel G.F., et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009, 361:2405-2413.
23. Ljungman P., Nahi H., Linde A. Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study. Br J Haematol 2005, 130:96-98.
24. Takata T., Suzumiya J., Ishikawa T., et al. Attenuated antibody reaction for the primary antigen but not for the recall antigen of influenza vaccination in patients with non-Hodgkin B-cell lymphoma after the administration of rituximab-CHOP. J Clin Exp Hematol 2009, 49:9-13.
25. Ge X., Tan V., Bollyky P.L., et al. Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. J Virol 2010, 84:3312-3319.
26. Greenbaum J.A., Kotturi M.F., Kim Y., et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci USA 2009, 106:20365-20370.
27. Hancock K., Veguilla V., Lu X., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361:1945-1952.
28. Pascua P.N., Song M.S., Lee J.H., et al. Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection. PLoS One 2009, 4:e8431.
29. Louie J.K., Acosta M., Winter K., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-1902.